Pain Medicine

Pain medicine has been reshaped by the opioid crisis, opioid-sparing perioperative pathways, and a growing armamentarium of interventional and neuromodulation techniques. GCSA 2027 will cover transitional pain services to prevent persistent postsurgical pain, multimodal regimens combining acetaminophen, NSAIDs, gabapentinoids (used judiciously), ketamine, and lidocaine infusions, and the role of suzetrigine (Nav1.8 inhibitor) as a non-opioid acute pain option. Interventional sessions address dorsal root ganglion stimulation, high-frequency and closed-loop spinal cord stimulation, radiofrequency ablation for facet and genicular pain, and intrathecal drug delivery.